This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yuan, J.-M. Articles by Ross, R. K. Search for Related Content PubMed PubMed Citation Articles by Yuan, J.-M. Articles by Ross, R. K.

Helicobacter pylori Infection and Risk of Gastric Cancer in Shanghai, China: Updated Results Based upon a Locally Developed and Validated Assay and Further Follow-Up of the Cohort¹

Department of Preventive Medicine, University of Southern California/Norris Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, California 90033-0800 [J.-M. Y., M. C. Y., M. C., R. K. R.]; Shanghai Institute of Digestive Diseases, Shanghai 200001, People’s Republic of China [W.-W. X.]; and Shanghai Cancer Institute, Shanghai 200032, People’s Republic of China [Y.-T. G.]

Infection with Helicobacter pylori has been associated with an increased risk of gastric cancer in low-risk populations. However, our previous results (P. M. Webb et al., Int. J. Cancer, 67: 603–607, 1996) from an ongoing prospective study in Shanghai, China, a relatively high-risk population, failed to show an association between H. pylori infection and the subsequent risk of gastric cancer. That previous study had a relatively short time period of follow-up and the enzyme-linked immunosorbent assay (ELISA) used was based on strains found in Southern England and without validation among the Chinese. Either one of these two factors could have had an impact on the validity of those earlier observations. An ELISA developed and validated among Shanghai residents was used in the present study to reexamine specific antibodies to H. pylori in 188 gastric cancer patients and 548 control subjects. All of the cases of gastric cancer were identified during the first 12 years of follow-up of a cohort of 18,244 men, ages 45–64 years in Shanghai, from whom blood samples were collected at enrollment during 1986–1989. For each cancer case, three cancer-free control subjects were randomly selected from the cohort and matched to the index cases by age (within 2 years), month and year of sample collection, and neighborhood of residence. The Shanghai-based ELISA detected a higher prevalence of serum antibodies to H. pylori than the English-based assay in both gastric cancer cases (86 versus 53%) and control subjects (85 versus 56%). Virtually all of the subjects (98%) who were H. pylori-seropositive by the English-based assay tested positive by the Shanghai-based assay. On the other hand, 73% of gastric cancer cases and 68% of control subjects who were seronegative according to the English-based assay tested positive by the Shanghai-based assay. Using this alternative assay, combined with increased follow-up, our latest data contradict our earlier findings and show a statistically significant association between H. pylori seropositivity and gastric cancer risk (odds ratio, 1.84; 95% confidence interval, 1.08–3.11). We noted an increasing rate of seropositivity among cases as the time interval between cohort enrollment and cancer diagnosis increased. Among subjects followed for 5 or more years after enrollment, the odds ratio for gastric cancer related to H. pylori seropositivity was 3.74 (95% confidence interval, 1.51–9.30).

This article has been cited by other articles:

				S. Sasazuki, M. Inoue, M. Iwasaki, T. Otani, S. Yamamoto, S. Ikeda, T. Hanaoka, S. Tsugane, and for the Japan Public Health Center Study Group Effect of Helicobacter pylori Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control Study. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1341 - 1347. [Abstract] [Full Text] [PDF]

				M. Okuda, T. Sugiyama, K. Fukunaga, M. Kondou, E. Miyashiro, and T. Nakazawa A Strain-Specific Antigen in Japanese Helicobacter pylori Recognized in Sera of Japanese Children Clin. Vaccine Immunol., November 1, 2005; 12(11): 1280 - 1284. [Abstract] [Full Text] [PDF]

				J.-M. Yuan, R. K. Ross, Y.-T. Gao, Y.-H. Qu, X.-D. Chu, and M. C. Yu Prediagnostic Levels of Serum Micronutrients in Relation to Risk of Gastric Cancer in Shanghai, China Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1772 - 1780. [Abstract] [Full Text] [PDF]

				P. A. Marchildon, T. Sugiyama, Y. Fukada, J. S. Peacock, M. Asaka, T. Shimoyama, and D. Y. Graham Evaluation of the Effects of Strain-Specific Antigen Variation on the Accuracy of Serologic Diagnosis of Helicobacter pylori Infection J. Clin. Microbiol., April 1, 2003; 41(4): 1480 - 1485. [Abstract] [Full Text] [PDF]

				Helicobacter and Cancer Collaborative Group Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts Gut, September 1, 2001; 49(3): 347 - 353. [Abstract] [Full Text] [PDF]

				P. J. Limburg, Y.-L. Qiao, S. D. Mark, G.-Q. Wang, G. I. Perez-Perez, M. J. Blaser, Y.-P. Wu, X.-N. Zou, Z.-W. Dong, P. R. Taylor, et al. Helicobacter pylori Seropositivity and Subsite-Specific Gastric Cancer Risks in Linxian, China J Natl Cancer Inst, February 7, 2001; 93(3): 226 - 233. [Abstract] [Full Text] [PDF]

				W.-c. You, L. Zhang, M. H. Gail, Y.-s. Chang, W.-d. Liu, J.-l. Ma, J.-y. Li, M.-l. Jin, Y.-r. Hu, C.-s. Yang, et al. Gastric Dysplasia and Gastric Cancer: Helicobacter pylori, Serum Vitamin C, and Other Risk Factors J Natl Cancer Inst, October 4, 2000; 92(19): 1607 - 1612. [Abstract] [Full Text] [PDF]